TOP > 外国特許検索 > CANCER MARKER AND APPLICATION THEREOF

CANCER MARKER AND APPLICATION THEREOF コモンズ

外国特許コード F130007634
整理番号 850-1336,S2014-0600-N0
掲載日 2013年10月1日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2013JP074377
国際公開番号 WO 2014042148
国際出願日 平成25年9月10日(2013.9.10)
国際公開日 平成26年3月20日(2014.3.20)
優先権データ
  • 特願2012-199508 (2012.9.11) JP
発明の名称 (英語) CANCER MARKER AND APPLICATION THEREOF コモンズ
発明の概要(英語) Provided is a new cancer marker for testing the morbidity risk of cancer. The cancer marker of this invention is a prorenin receptor. The method for testing the morbidity risk of cancer of this invention is a method which measures the expression of prorenin receptors in a biological sample of a subject, and further includes, for example, a step in which the morbidity risk of cancer of the subject is tested by comparing the level of expression of prorenin receptors in the biological sample of the subject with a reference value. The reference value is the level of expression of prorenin receptors in the biological sample of healthy subjects or the level of expression of prorenin receptors in the biological samples of cancer patients. If the level of expression in the subject is higher than the level of expression in a healthy subject, is the same as the level of expression in the cancer patient, or is higher than the level of expression in the cancer patient, the subject is deemed to have a risk of dying from cancer.
従来技術、競合技術の概要(英語) BACKGROUND ART
In recent years, the cancer is, the top cause of death in Japanese and, also in other countries, the leading cause of death ranking are expelled. And development is the occurrence of cancer, genetic factors, environmental factors such as related to the different factors, definitive diagnosis and therapeutic method, not yet been established.
Cancer among, for example, pancreatic cancer, early detection is difficult for progresses quickly, at the time of discovery, transferred to the surrounding lymph nodes and organs such as in many cases. In this way, in the stages of therapy, a cancer progress, for example, and difficult to treat, even when surgical operation and the problem of a poor prognosis. For this reason, various for cancer including pancreatic cancer, and early detection of cancer marker for the development of desired (non-patent document 1 and 2).
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
  • GIFU UNIVERSITY
  • 発明者(英語)
  • Nishiyama formation
  • Fumiaki Suzuki
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IS JP KE KG KN KP KR KZ LA LC LK LR LS LT LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN TD TG
四国TLOは四国内20大学・高専のシーズをご紹介しております。シーズの詳細内容につきましては下記までお問い合わせください。
お問い合わせをお待ちしております。

PAGE TOP

close
close
close
close
close
close